JENNIFER WICKLUND: Open Payments
NPI 1871165118 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 19 payments from 8 companies in 2025. Trend: 2023 $515 · 2024 $938 · 2025 $536
Food & beverage: $339Education: $197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $170 |
| Regeneron Healthcare Solutions, Inc. | 2 | $126 |
| Janssen Biotech, Inc. | 2 | $122 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Lilly USA, LLC | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $17 |
| LEO Pharma Inc. | 1 | $14 |
| Organon LLC | 1 | $8 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, COSENTYX, OLUMIANT, XOLAIR, NEMLUVIO, ADBRY.
Industry payments across ID — which companies pay providers there.
